A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males

Clinical trial NCT02484729 · COMPLETED

Trial details

NCT number: NCT02484729
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Tolerability Pharmacokinetics Healthy Subjects

Start date: 2015-07-01
Primary completion: 2015-11-01
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.